Navigation Links
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Date:4/8/2008

be used as monotherapy or concomitantly with MTX in pediatric patients. ORENCIA should not be administered concomitantly with TNF antagonists. ORENCIA is not recommended for use concomitantly with other biologic RA therapy, such as anakinra.

For adult patients with RA, ORENCIA, a lyophilized powder for intravenous infusion, should be administered by a healthcare professional as a 30-minute intravenous infusion at a fixed dose based on body weight range approximating 10 mg/kg. Following the initial administration, ORENCIA should be given at two and four weeks after the first infusion and every four weeks thereafter. Acute infusion-related reactions were experienced in nine percent of people treated with ORENCIA and in six percent of people treated with placebo. The most frequently reported infusion-related adverse events (one percent to two percent) were dizziness, headache, and hypertension. In clinical studies, premedications were not required. However, appropriate medical support measure of the treatment of hypersensitivity reactions should be available for immediate use in the event of a reaction.

For pediatric and adolescent patients with JIA who weigh less than 75 kg, ORENCIA(R) (abatacept) should be administered as a 30-minute intravenous infusion at a dose of 10 mg/kg specifically calculated based on the patient's body weight at each administration, not to exceed a maximum dose of 1000 mg. Pediatric patients weighing 75 kg or more should be administered ORENCIA following the adult dosing regimen. Following the initial administration, ORENCIA should be given at two and four weeks after the first infusion and every four weeks thereafter. ORENCIA may be used as monotherapy or concomitantly with MTX.

About Bristol-Myers Squibb

Bristol-Myers Squibb Company is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.

1 FDA Website. Approval History: sBLA 125057/
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... SINGAPORE , April 17, 2015 ... a leading Life Science and High Technology company, ... Asia Pacific headquarters and state-of-the-art Cell ... Research Park, the facility will provide customized support ... leading scientific capabilities. "Our new Technical ...
(Date:4/16/2015)... April 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of products for the treatment ... release results for the first quarter of 2015 on ... The Company will host a conference call ... during which Vanda management will discuss the first quarter ...
(Date:4/16/2015)... BEDFORD, Mass. , April 16, 2015 /PRNewswire/ ... an important cervical cancer screening study i ... , a peer-reviewed journal of the American Cancer ... Quest Diagnostics and the University of Pittsburgh Medical Center, supports ... screening, which recommend that women 30-65 years of ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... , ATLANTA , Feb. 1 ... that provides healthcare professionals, patients, investors and the public with ... solutions for treating cancer and brain disorders. , Designed ... functionality, including a new, clean design that appeals to a ...
... NANTONG, China , ... "Company") (OTC Bulletin Board: SNBP) is pleased to,announce that ... (Cisatracurium Besylate), for coverage under National Basic,Medical Insurance, Employment ... KuTai (Cisatracurium Besylate), on the market since ...
Cached Medicine Technology:Elekta Launches New Web Site for Global Health Care Community 2Elekta Launches New Web Site for Global Health Care Community 3China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 2China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 3
(Date:4/17/2015)... (PRWEB) April 17, 2015 In Defense ... the following statement: “On Wednesday April 15th, the European ... adopted a resolution recognizing the Armenian Genocide, “paying tribute, ... of the one-and-a-half million innocent Armenian victims who perished ... (IDC) extols the EU for this timely and needed ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 As a ... in his new offering of platelet-rich plasma (PRP) ... Medicine (MOSM) is known for its world-class care ... brings extensive surgical experience lacking in many other physicians ... cell treatments are utilized for pain management and rehabilitation. ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... Connie Casad, M.D., a well-known and respected gynecologist, ... years of practice experience in Dallas, Texas, has announced ... for her patients with the availability of a reader’s ... with a brief synopsis on each for her patients. ... providing this service, Dr. Casad said, “Furnishing a researched ...
(Date:4/17/2015)... Jersey City, NJ (PRWEB) April 17, 2015 ... is stored in the posterior pituitary and thought to ... strengthening bonding between couples. To further substantiate this, new ... published in the journal, Nature, and reported by Medical ... does have a powerful influence over maternal social behavior. ...
Breaking Medicine News(10 mins):Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... head of the World Health Organization (WHO), Dr Anders Nordstrom, ... // , confirmed that Dr Anders Nordstrom. He also emphasized ... the people to continue the fight against HIV/Aids, malaria and ... work of his predecessor Dr Lee Jong-wook, who had passed ...
... detect AIDS. It is waiting for the FDA to give ... The Nasdaq-listed company already sells the kit to hospitals and ... this product would become an important weapon to fight against ... diagnosis was made. Statistics show that more than one million ...
... Scotland (HPS) said that a new strain of E. coli ... had been seen in Europe and Australia, but is apparently ... reacts differently in the laboratory from other types of E.coli ... out more about it,' said HPS consultant Dr John Cowden. ...
... Canada's health ministry asked patients suffering from high blood ... ailments such as hardening of the arteries // , ... Disorder (ADHD) drugs. This is because there is an ... rare heart-related side effects. Health Canada also asked the ...
... breastfed their babies in public are put under jail for ... that breastfeeding was an adverse thing, clinicians proved it is ... Healthy People 2010 target is to increase the proportion of ... six months to 50%; the World Health Organization recommends that ...
... have warned that the growing menace of potentially lethal ... there would be a global health crisis. ... the developed and developing world," said Jo Harkness, of ... penalties for counterfeits are shocking. Countering supply chains is ...
Cached Medicine News:Health News:Breastfeeding Mothers Arrested For Public Indecency 2
... a low-profile, wraparound, hinged knee product with ... patients who have difficulty applying a sleeve, ... for ease of application. These pull ... easily secure the anterior closure of the ...
... might just be the world's most versatile ... support, post-op/rehab support, or both, Flex is ... Accutrac™ ROM hinges control flexion and extension ... durability while being heat-moldable to accommodate changes ...
... CartiCare enables unloading of the medial or ... with unicompartmental osteoarthritis. Plus, we equipped this ... hinge, making it further suitable for post-op ... and/or adjustable flexion/extension control. , ,Indications: ...
... of the Custom Montana2 alleviates the ... three-point load across the knee joint, ... area. The Diagonal Loading Strap gives ... the load to accommodate their daily ...
Medicine Products: